Evidence map›Paper›PMID 22634755›Full record

SynthesisNature genetics2012

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk.

Malcolm G Dunlop, Sara E Dobbins, Susan Mary Farrington, Angela M Jones, Claire Palles, Nicola Whiffin, Albert Tenesa, Sarah Spain, Peter Broderick, Li-Yin Ooi and 57 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Nature genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 155 papers, 19 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
155citing papers in PubMed, 19 pooled it
22.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

155 citing papers in PubMed, 19 syntheses or guidelines pooled it, 229 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Germline variants and advanced colorectal adenomas: adenoma prevention with celecoxib trial genome-wide association study.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Pooled it
  18. Pooled it
  19. Pooled it
  20. Trial

95 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

67 authors at 20 institutions in 8 countries.

Malcolm G DunlopColon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh, UK. malcolm.dunlop@hgu.mrc.ac.uk
Sara E Dobbins
Susan Mary Farrington
Angela M Jones
Claire Palles
Nicola Whiffin
Albert Tenesa
Sarah Spain
Peter Broderick
Li-Yin Ooi
Enric Domingo
Claire Smillie
Marc Henrion
Matthew Frampton
Lynn Martin
Graeme Grimes
Maggie Gorman
Colin Semple
Yusanne P Ma
Ella Barclay
James Prendergast
Jean-Baptiste Cazier
Bianca Olver
Steven Penegar
Steven Lubbe
Ian Chander
Luis G Carvajal-Carmona
Stephane Ballereau
Amy Lloyd
Jayaram Vijayakrishnan
Lina Zgaga
Igor Rudan
Evropi Theodoratou
Colorectal Tumour Gene Identification (CORGI) Consortium
John M Starr
Ian Deary
Iva Kirac
Dujo Kovacević
Lauri A Aaltonen
Laura Renkonen-Sinisalo
Jukka-Pekka Mecklin
Koichi Matsuda
Yusuke Nakamura
Yukinori Okada
Steven Gallinger
David J Duggan
David Conti
Polly Newcomb
John Hopper
Mark A Jenkins
Fredrick Schumacher
Graham Casey
Douglas Easton
Mitul Shah
Paul Pharoah
Annika Lindblom
Tao Liu
Swedish Low-Risk Colorectal Cancer Study Group
Christopher G Smith
Hannah West
Jeremy P Cheadle
COIN Collaborative Group
Rachel Midgley
David J Kerr
Harry Campbell
Ian P Tomlinson
Richard S Houlston
Centre for Human Genetics · GBInstitute of Cancer Research · GBInstitute of Genetics and Cancer · GBUniversity of Cambridge · GBThe University of Melbourne · AUUniversity of Oxford · GBHelsinki University Hospital · FIKarolinska Institutet · SEMount Sinai Hospital · CAUniversity of Edinburgh · GBUniversity of Helsinki · FIUniversity of Southern California · USCardiff University · GBNational Institute for Health Research · GBRIKEN · JPRoyal Devon and Exeter Hospital · GBSisters of Charity Hospital · HRTranslational Genomics Research Institute · USUniversity Hospital Centre Zagreb · HRUniversity of Eastern Finland · FI

Funding

USC Consortium:Colorectal Cancer Family RegistryU01CA074799 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HAILE, ROBERT WILLIAM · 1997 to 2008
$20.4M
SEATTLE FAMILIAL COLORECTAL CANCER REGISTRYU01CA074794 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI NEWCOMB, POLLY A · 1997 to 2007
$14.1M
ONTARIO REGISTRY FOR STUDIES OF FAMILIAL COLON CANCERU01CA074783 · NCI · CANCER CARE ONTARIO · PI GALLINGER, STEVEN · 1997 to 2008
$12.5M
Genomic Wide Association Study of Colorectal CancerU01CA122839 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CASEY, GRAHAM · 2006 to 2010
$7.3M
AUSTRALASIAN COLORECTAL CANCER FAMILY REGISTRYU01CA097735 · NCI · UNIVERSITY OF MELBOURNE · PI HOPPER, JOHN L · 2002 to 2007
$6.9M
Redox Regulation of Metastasis by Sod2K22CA095011 · NCI · ALBANY MEDICAL COLLEGE · PI MELENDEZ, JUAN ANDRES · 2002 to 2004
$446k
Biotechnology and Biological Sciences Research CouncilCancer Research UK 10124Cancer Research UK 10589Cancer Research UK 12076Cancer Research UK C10195/A12996Cancer Research UK C10314/A4886Cancer Research UK C1298/A8362Cancer Research UK C31250/A10107Cancer Research UK C348/A12076Cancer Research UK C490/A10124Medical Research Council G1002033Medical Research Council MC_U122861325Medical Research Council MC_U127527198NCI NIH HHS CA-95-011NCI NIH HHS U01 CA074783NCI NIH HHS U01 CA074794NCI NIH HHS U01 CA074799NCI NIH HHS U01 CA097735NCI NIH HHS U01 CA122839NCI NIH HHS U01CA122839Wellcome Trust 076113/C/04/ZWellcome Trust 090532Wellcome Trust 090532/Z/09/ZWorldwide Cancer Research 05-0001
6 · The paper itself

Abstract

We performed a meta-analysis of five genome-wide association studies to identify common variants influencing colorectal cancer (CRC) risk comprising 8,682 cases and 9,649 controls. Replication analysis was performed in case-control sets totaling 21,096 cases and 19,555 controls. We identified three new CRC risk loci at 6p21 (rs1321311, near CDKN1A; P = 1.14 × 10(-10)), 11q13.4 (rs3824999, intronic to POLD3; P = 3.65 × 10(-10)) and Xp22.2 (rs5934683, near SHROOM2; P = 7.30 × 10(-10)) This brings the number of independent loci associated with CRC risk to 20 and provides further insight into the genetic architecture of inherited susceptibility to CRC.

Indexed as

Case-Control StudiesColorectal NeoplasmsCyclin-Dependent Kinase Inhibitor p21DNA Polymerase IIIGenetic LociGenetic Predisposition to DiseaseGenetic VariationGenome-Wide Association StudyHumansMembrane ProteinsCDKN1A protein, humanCyclin-Dependent Kinase Inhibitor p21DNA Polymerase IIIMembrane ProteinsPOLD3 protein, humanSHROOM2 protein, human

Identifiers

PMID22634755
PMCPMC4747430
OpenAlexW2096920403

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.